Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 7/20 | 0.51 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.50 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.50 |
| ▸ | CDK2 | P24941 | 3/20 | 0.50 |
| ▸ | CDK9 | P50750 | 3/20 | 0.50 |
| ▸ | CSNK1E | P49674 | 3/20 | 0.50 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.50 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.50 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.50 |
| ▸ | FEN1 | P39748 | 2/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.47 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.47 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.47 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | PRKACA | P17612 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15638546 | 0.81 | FEN1 (0.49) | MAPK14CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL9956071 | 0.81 | ADORA1 (0.64) | MAPK14CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL28019394 | 0.79 | FEN1 (0.47) | MAPK14CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL6579207 | 0.79 | MAPK14 (0.53) | MAPK14CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL17200126 | 0.79 | HSP90AA1 (0.66) | MAPK14CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL29889857 | 0.78 | CDK5 (0.53) | CCNT1CCNA2CDK2CDK9CDK5 | |
| SCHEMBL21908761 | 0.78 | CDK5 (0.53) | CCNT1CCNA2CDK2CDK9CDK5 | |
| SCHEMBL1645470 | 0.77 | CCNT1 (0.53) | MAPK14CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL30117887 | 0.77 | PTGS2 (0.51) | MAPK14CCNA2CDK2CSNK1EFEN1 | |
| SCHEMBL15638432 | 0.77 | PTGS2 (0.51) | MAPK14CCNA2CDK2CSNK1EFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140083-A4 | NOVEL COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2004-01-02 | — | — | EP | claimed |
| US-6469018-B1 | INHIBITING CYTOKINES AND THE TREATMENT OF A CYTOKINE MEDIATED DISEASE, BY ADMINISTRATION OF COMPOUNDS SUCH AS:2-(4-FLUOROPHENYL)-3-(2-METHYLTHIOPYRIMIDIN-4-YL)PYRIDINE | SMITHKLINE BEECHAM CORPORATION | 2002-10-22 | — | — | US | claimed |
| EP-1140083-A1 | NOVEL COMPOUNDS | SmithKline Beecham Corporation (US) | 2001-10-10 | — | — | EP | claimed |
| WO-2000040243-A1 | NOVEL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-13 | — | — | WO | claimed |
| EP-1140083-A4 | NOVEL COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2004-01-02 | — | — | EP | disclosed |
| US-6469018-B1 | INHIBITING CYTOKINES AND THE TREATMENT OF A CYTOKINE MEDIATED DISEASE, BY ADMINISTRATION OF COMPOUNDS SUCH AS:2-(4-FLUOROPHENYL)-3-(2-METHYLTHIOPYRIMIDIN-4-YL)PYRIDINE | SMITHKLINE BEECHAM CORPORATION | 2002-10-22 | — | — | US | disclosed |
| EP-1140083-A1 | NOVEL COMPOUNDS | SmithKline Beecham Corporation (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000040243-A1 | NOVEL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-13 | — | — | WO | disclosed |